Hebei Weimiao Biology Co., LTD 1
مقام

بلاگ

  • Pharma Intermediates and Fine Chemicals: An Explainer 

    Pharma Intermediates and Fine Chemicals: An Explainer 

    Pharma intermediates and fine chemicals form the backbone of pharmaceutical manufacturing, facilitating the synthesis, formulation, and quality control of a wide range of medications. Their efficient utilization enhances production processes, ensures product purity and quality, and enables customized drug development. By supporting research and development endeavors, these chemicals contribute to advancements in the pharmaceutical industry, ultimately benefiting patients worldwide with safer, more effective, and innovative medicines. 
    وڌيڪ پڙهو
  • The Role of Pharmaceutical Intermediates in Accelerating Drug Development and Production

    The Role of Pharmaceutical Intermediates in Accelerating Drug Development and Production

    In the fast-paced world of medicine, pharmaceutical companies play a vital role in quickly getting new drugs to us. These companies know a lot about medicines, have top-notch equipment, and understand all the rules to speed up making new drugs. But have you ever wondered how these pharmaceutical development firms make those life-saving medications we rely on? It’s a fascinating process that involves several stages, and one crucial element in this journey is pharmaceutical intermediates. These unsung heroes play a huge role in speeding up drug development and production, ultimately getting essential medications to the market faster. In this blog, we will dive deeper into their significance.
    وڌيڪ پڙهو
  • Cell Culture Media: An Active Pharmaceutical Ingredient or Ancillary Material?

    Cell Culture Media: An Active Pharmaceutical Ingredient or Ancillary Material?

    Cell-based therapies are used to treat diseases that require the replacement of diseased, dysfunctional, and injured cells (1). To produce these therapies, a wide range of reagents and materials such as antibodies, growth factors, and enzymes are used in their manufacturing processes. Such necessary materials are administered through a cell culture medium. Active pharmaceutical ingredients (APIs) are the main ingredients that make products therapeutic. Ancillary materials (AMs) and raw materials (RMs) are essential components used during production but are not supposed to be present in final products. Some advances in cell-based therapies have revealed inconsistencies and lack of regulation in classifying materials that are used to produce these products as RMs, AMs, and APIs. Clear guidelines and regulations are needed regarding RMs and AMs in cell-based therapies.
    وڌيڪ پڙهو
  • Handling Potent Active Pharmaceutical Ingredients

    Handling Potent Active Pharmaceutical Ingredients

    APIs are a critical component of the pharmaceutical supply chain and are a fundamental part and cornerstone of medical therapies! API pipelines have become more potent and toxic in the last 10 years, and continue to do so, this could not be more evident than in the antibody drug conjugate (ADC) space. It remains important that biopharmaceutical companies integrate potent API management and handling concepts in to their daily operations. For almost 20 years, Justin Mason-Home, founder of HPAPI Project Services Limited, has been a recognized expert in supporting pharmaceutical companies in the delivery of potent API projects.
    وڌيڪ پڙهو
  • How DSC Assists in Characterizing Active Pharmaceutical Ingredients

    How DSC Assists in Characterizing Active Pharmaceutical Ingredients

    For the treatment of diseases, the pharmaceutical industry continuously strives for research on new pharmaceutical ingredients (APIs). Dr. Carsten Schauerte from SOLID-CHEM GmbH will show you how DSC can assist in characterizing active pharmaceutical ingredients.Dr. Carsten Schauerte is co-founder and managing director of SOLID-CHEM GmbH at the Biomedical Center in Bochum, Germany. He graduated with a degree in Chemistry from the University of Essen, received his doctorate in 2004 and worked as a postdoc at the Goethe University in Frankfurt am Main.
    وڌيڪ پڙهو
  • HIGHLY ACTIVE PHARMACEUTICAL INGREDIENTS (HAPI)

    HIGHLY ACTIVE PHARMACEUTICAL INGREDIENTS (HAPI)

    All over the world, the manufacturers of pharmaceuticals are increasingly working and researching with highly potent active pharmaceutical ingredients (HPAPI). This paves the way for new therapies which make it possible to treat patients with lower doses at a simultaneously higher effectiveness of the active ingredients.
    وڌيڪ پڙهو
  • Active Pharmaceutical Ingredient (API) 

    Active Pharmaceutical Ingredient (API) 

    An active pharmaceutical ingredient, abbreviated as API, is a substance used to produce a pharmaceutical product. API’s can have a direct impact on an indication. The active pharmaceutical ingredients or substances can eventually be converted into a drug or medicine.The pharmacological activity of any API plays a direct role in the diagnosis, mitigation, cure, treatment, and disease prevention.  API’s affect the structure and the functioning of the human body.Medicines or pharmaceutical compounds all have inactive ingredients that are referred to as bulk pharmaceutical chemicals (BPCs).
    وڌيڪ پڙهو
  • What is the Difference Between API and Pharmaceutical Intermediates? 

    What is the Difference Between API and Pharmaceutical Intermediates? 

    Have you ever wondered about the differences between API (Active Pharmaceutical Ingredient) and pharmaceutical intermediates? If so, then this blog post is for you! Here, we’ll explore what exactly makes up these components of medicines, their differences, and how they come together to create powerful treatments. We’ll also look at why understanding both API and pharmaceutical intermediates can be crucial when it comes to selecting a quality medication. Keep reading to find out more! 
    وڌيڪ پڙهو
  • What are Active Pharmaceutical Ingredients (API)?

    What are Active Pharmaceutical Ingredients (API)?

    China created a low-cost API manufacturing industry. The industry was backed by the low cost of capital followed by aggressive government funding models, tax incentives. Their cost of operation is one-fourth of India’s cost. Even the cost of finance in China is 6-7 per cent against India’s 13-14 per cent.So, due to low-profit margins and non-lucrative industry, Indian pharma companies over the years stopped manufacturing APIs.
    وڌيڪ پڙهو

جيڪڏھن توھان اسان جي پروڊڪٽس ۾ دلچسپي رکو ٿا، توھان پنھنجي معلومات کي ھتي ڇڏڻ جو انتخاب ڪري سگھو ٿا، ۽ اسان جلد ئي توھان سان رابطي ۾ ھونداسين.


دٻايو داخل ڪرڻ لاءِ ڳولا يا ESC بند ڪرڻ لاءِ
sdSindhi
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu sdSindhi